NICE-aligned management typically involves: Addressing modifiable risk factors (smoking cessation, weight loss, increased physical activity, alcohol reduction) Optimising management of underlying conditions (diabetes, hypertension, depression) Trial of PDE5 inhibitor therapy Referral to specialist services (urology/andrology) if first-line treatments fail or where structural/neurological/endocrine causes are suspected Consideration of psychosexual therapy where appropriate Men should be reassured that ED is a medical condition with effective treatments, and seeking help through proper channels ensures safety, appropriate investigation of underlying causes, and access to evidence-based therapies
GLP-Based Injectable Therapies Our medically supervised weight-loss programs use advanced GLP-1, GIP, and glucagon receptorbased peptides to support fat loss, appetite control, metabolic health, and long-term sustainability
Protein kinase B is obligatory for follicle-stimulating hormone-induced granulosa cell differentiation
Research interest in BPC-157 stems from its broad involvement in multiple biological signaling systems
It is a core part of the US peptide supply chain at the industrial level
In vitro studies using human diploid fibroblast cultures approaching replicative senescence have investigated whether Epithalamin modulates hTERT promoter activity and enzymatic telomerase activity as measured by TRAP assay
